T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCRN
2276
DELISTED
Cross Country Healthcare
CCRN
| $359K | ﹤0.01% |
+12,766
| New | +$317K |
|
2277
AMC Global Media
AMCX
$496M
| $353K | ﹤0.01% |
29,461
+1,786
| +6% | +$25.8K |
|
2278
Anavex Life Sciences
AVXL
$303M
| $353K | ﹤0.01% |
43,369
+875
| +2% | +$7.5K |
|
|
VBTX
2279
DELISTED
Veritex Holdings
VBTX
| $353K | ﹤0.01% |
19,648
+847
| +5% | +$15.1K |
|
2280
Interface
TILE
$2.24B
| $352K | ﹤0.01% |
40,012
+854
| +2% | +$6.55K |
|
2281
Covenant Logistics
CVLG
$880M
| $351K | ﹤0.01% |
15,976
+352
| +2% | +$6.8K |
|
2282
Domo
DOMO
$187M
| $351K | ﹤0.01% |
23,910
+450
| +2% | +$6.64K |
|
|
OPI
2283
DELISTED
Office Properties Income Trust
OPI
| $351K | ﹤0.01% |
45,578
-1,068
| -2% | -$8.08K |
|
|
BORR
2284
Borr Drilling
BORR
$1.25B
| $350K | ﹤0.01% |
46,355
+7,501
| +19% | +$53.7K |
|
2285
Vera Bradley
VRA
$94.7M
| $350K | ﹤0.01% |
54,735
+935
| +2% | +$5.28K |
|
2286
Conduent
CNDT
$252M
| $349K | ﹤0.01% |
102,507
-23,768
| -19% | -$77.8K |
|
2287
Customers Bancorp
CUBI
$2.82B
| $349K | ﹤0.01% |
11,529
+387
| +3% | +$8.67K |
|
2288
HealthStream
HSTM
$849M
| $349K | ﹤0.01% |
14,183
+333
| +2% | +$8.26K |
|
|
SLCA
2289
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $349K | ﹤0.01% |
28,706
+1,198
| +4% | +$14.8K |
|
|
TGH
2290
DELISTED
Textainer Group Holdings limited
TGH
| $349K | ﹤0.01% |
8,847
+456
| +5% | +$16.6K |
|
|
HIBB
2291
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $349K | ﹤0.01% |
9,601
-7,446
| -44% | -$356K |
|
|
TDAY
2292
USA Today Co
TDAY
$1B
| $348K | ﹤0.01% |
154,268
+7,969
| +5% | +$15.9K |
|
2293
PubMatic
PUBM
$787M
| $347K | ﹤0.01% |
18,979
+501
| +3% | +$7.96K |
|
|
CDMO
2294
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $346K | ﹤0.01% |
24,748
+872
| +4% | +$14.9K |
|
2295
Barrett Business Services
BBSI
$800M
| $345K | ﹤0.01% |
15,792
+312
| +2% | +$6.68K |
|
2296
Fluence Energy
FLNC
$2.44B
| $345K | ﹤0.01% |
+12,919
| New | +$289K |
|
2297
Mirion Technologies
MIR
$3.88B
| $343K | ﹤0.01% |
40,586
+14,898
| +58% | +$121K |
|
2298
RCI Hospitality Holdings
RICK
$230M
| $343K | ﹤0.01% |
4,507
+88
| +2% | +$6.61K |
|
2299
4D Molecular Therapeutics
FDMT
$609M
| $342K | ﹤0.01% |
18,920
+539
| +3% | +$9.92K |
|
2300
MGP Ingredients
MGPI
$389M
| $342K | ﹤0.01% |
3,212
+509
| +19% | +$50.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.